A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene).
Anti-neoplastic drugs have made major advancements in oncology, however they are not without cardiovascular consequences. We present a patient with cutaneous T-cell lymphoma receiving Targretin therapy who presented with accelerated atherosclerosis. His triglyceride level (TG) was greater than 1000 mg/dL, which rapidly improved with discontinuation of Targretin.
Published In/Presented At
DeAngelo, S., Mann, K. I., Abdulbasit, M., Ahnert, A., & Sundlöf, D. W. (2020). A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene). Cardio-oncology (London, England), 6(1), 31. https://doi.org/10.1186/s40959-020-00087-3
Cardiology | Medicine and Health Sciences
Peer Reviewed for front end display
Department of Medicine, Cardiology Division, Department of Medicine Faculty